The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study.

LAT2 may be a potential protective factor for diabetic retinopathy, offering preliminary insight for future biomarker development and prevention strategies.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-01-01
DOI
https://doi.org/10.3389/fendo.2025.1638661
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study.

Ming Yang, Weizhen Wu
1 links
PubMed
Diabetes Treatment and Management
article

The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study.

Ming Yang, Weizhen Wu
article en

Abstract

LAT2 may be a potential protective factor for diabetic retinopathy, offering preliminary insight for future biomarker development and prevention strategies.

PubMedVol. 16
Beijing Friendship Hospital (CN)
Openalex Percentile: Top 73%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study. — Ming Yang, Weizhen Wu · PubMed (2025) | TGRS Research Map | TGRS